Reply

Affiliations

¹ Kyorin University School of Medicine, Tokyo, Japan. Electronic address: aokada@eye-center.org.
² Kyorin University School of Medicine, Tokyo, Japan.
³ Tokyo Women's Medical University, Tokyo, Japan.
⁴ Fukushima Medical University, Fukushima, Japan.

Comment

Annabelle A Okada et al. Ophthalmology. 2016 Feb.

. 2016 Feb;123(2):e13-e14.

doi: 10.1016/j.ophtha.2015.08.032.

¹ Kyorin University School of Medicine, Tokyo, Japan. Electronic address: aokada@eye-center.org.
² Kyorin University School of Medicine, Tokyo, Japan.
³ Tokyo Women's Medical University, Tokyo, Japan.
⁴ Fukushima Medical University, Fukushima, Japan.

No abstract available

Comment on

One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
Yamamoto A, Okada AA, Kano M, Koizumi H, Saito M, Maruko I, Sekiryu T, Iida T. Yamamoto A, et al. Ophthalmology. 2015 Sep;122(9):1866-72. doi: 10.1016/j.ophtha.2015.05.024. Epub 2015 Jun 16. Ophthalmology. 2015. PMID: 26088619
Re: Yamamoto et al.: One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy (Ophthalmology 2015;122:1866-72).
Kim JH. Kim JH. Ophthalmology. 2016 Feb;123(2):e13. doi: 10.1016/j.ophtha.2015.08.026. Ophthalmology. 2016. PMID: 26802716 No abstract available.